SALMONELLA-TYPHI VACCINE STRAIN CVD-908 EXPRESSING THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM - STRAIN CONSTRUCTION AND SAFETY AND IMMUNOGENICITY IN HUMANS

被引:99
作者
GONZALEZ, C
HONE, D
NORIEGA, FR
TACKET, CO
DAVIS, JR
LOSONSKY, G
NATARO, JP
HOFFMAN, S
MALIK, A
NARDIN, E
SZTEIN, MB
HEPPNER, DG
FOUTS, TR
ISIBASI, A
LEVINE, MM
机构
[1] UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[2] NATL NAVAL MED CTR, BETHESDA, MD 20814 USA
[3] INST MEXICANO SEGURO SOCIAL, UNIDAD INVEST MED & IMMUNOQUIM, MEXICO CITY, DF, MEXICO
[4] NYU, SCH MED, DEPT MED & MOLEC PARASITOL, NEW YORK, NY USA
关键词
D O I
10.1093/infdis/169.4.927
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of P-tac was integrated into the chromosomal Delta aroC locus of attenuated Delta aroC, Delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 Omega(Delta aroC1019::P-tac-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8(+) cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 37 条
[31]   Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the asd-balanced lethal vector system (vol 65, pg 3383, 1997) [J].
Tacket, CO ;
Kelly, SM ;
Schodel, F ;
Losonsky, G ;
Nataro, JP ;
Edelman, R ;
Levine, MM ;
Curtiss, R .
INFECTION AND IMMUNITY, 1997, 65 (09) :3981-3981
[32]   Adaptation of the endogenous Salmonella enterica serovar typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA [J].
Galen, JE ;
Zhao, LC ;
Chinchilla, M ;
Wang, JY ;
Pasetti, MF ;
Green, J ;
Levine, MM .
INFECTION AND IMMUNITY, 2004, 72 (12) :7096-7106
[33]   SAFETY AND IMMUNOGENICITY OF A LIVE ORAL BIVALENT TYPHOID-FEVER (SALMONELLA-TYPHI TY21A) CHOLERA (VIBRIO-CHOLERAE CVD 103-HGR) VACCINE IN HEALTHY-ADULTS [J].
CRYZ, SJ ;
QUE, JU ;
LEVINE, MM ;
WIEDERMANN, G ;
KOLLARITSCH, H .
INFECTION AND IMMUNITY, 1995, 63 (04) :1336-1339
[34]   Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I [J].
Turner, AK ;
Beavis, JC ;
Stephens, JC ;
Greenwood, J ;
Gewert, C ;
Thomas, N ;
Deary, A ;
Casula, G ;
Daley, A ;
Kelly, P ;
Randall, R ;
Darsley, MJ .
INFECTION AND IMMUNITY, 2006, 74 (02) :1062-1071
[35]   Engineered Delta guaB-A Delta virG Shigella flexneri 2a strain CVD 1205: Construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine [J].
Noriega, FR ;
Losonsky, G ;
Lauderbaugh, C ;
Liao, FM ;
Wang, JY ;
Levine, MM .
INFECTION AND IMMUNITY, 1996, 64 (08) :3055-3061
[36]   Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD- S. Typhi-specific IgA and IgG B memory cells in humans [J].
Wahid, Rezwanul ;
Pasetti, Marcela F. ;
Maciel, Milton, Jr. ;
Simon, Jakub K. ;
Tacket, Carol O. ;
Levine, Myron M. ;
Sztein, Marcelo B. .
CLINICAL IMMUNOLOGY, 2011, 138 (02) :187-200
[37]   Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi TY2 chi 4297 (Delta cya Delta crp Delta asd): safety and immunogenicity in mice [J].
Zhang, TH ;
Stanley, SL .
VACCINE, 1997, 15 (12-13) :1319-1322